Loading clinical trials...
Loading clinical trials...
A Prospective, Randomized and Non-randomized, Controlled, Single-blind and Open-label, Dose-finding, Multi-center, Parallel Group Study of Safety/Efficacy of KUR-113 Bone Graft Versus Local Autograft for the Treatment of Single-level Transforaminal Lumbar Interbody Fusion
Conditions
Interventions
TGplPTH1-34 in fibrin
Autologous Bone Graft
Locations
15
United States
University of California San Diego
La Jolla, California, United States
Justin Parker Neurological Institute
Boulder, Colorado, United States
MedStar Georgetown University Hospital
Washington D.C., District of Columbia, United States
Northwestern University-Northwestern Memorial Hospital
Chicago, Illinois, United States
Indiana Spine Group
Carmel, Indiana, United States
Kansas Spine and Specialty Hospital
Wichita, Kansas, United States
Start Date
August 27, 2020
Primary Completion Date
July 30, 2024
Completion Date
July 30, 2025
Last Updated
August 9, 2023
NCT07127380
NCT07254806
NCT05508360
NCT05037968
NCT05029726
NCT06011551
Lead Sponsor
Kuros Biosurgery AG
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions